FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:AAK1-NOP58

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: AAK1-NOP58
FusionPDB ID: 64
FusionGDB2.0 ID: 64
HgeneTgene
Gene symbol

AAK1

NOP58

Gene ID

112268437

51602

Gene nameuncharacterized protein FLJ45252NOP58 ribonucleoprotein
SynonymsAAK1HSPC120|NOP5|NOP5/NOP58
Cytomap

-

2q33.1

Type of geneprotein-codingprotein-coding
Descriptionuncharacterized protein FLJ45252alternative protein AAK1nucleolar protein 58NOP58 ribonucleoprotein homolognucleolar protein 5nucleolar protein NOP5/NOP58
Modification date2020030320200313
UniProtAcc

Q2M2I8

Main function of 5'-partner protein: FUNCTION: Regulates clathrin-mediated endocytosis by phosphorylating the AP2M1/mu2 subunit of the adaptor protein complex 2 (AP-2) which ensures high affinity binding of AP-2 to cargo membrane proteins during the initial stages of endocytosis (PubMed:17494869, PubMed:11877457, PubMed:11877461, PubMed:12952931, PubMed:14617351, PubMed:25653444). Isoform 1 and isoform 2 display similar levels of kinase activity towards AP2M1 (PubMed:17494869). Preferentially, may phosphorylate substrates on threonine residues (PubMed:11877457, PubMed:18657069). Regulates phosphorylation of other AP-2 subunits as well as AP-2 localization and AP-2-mediated internalization of ligand complexes (PubMed:12952931). Phosphorylates NUMB and regulates its cellular localization, promoting NUMB localization to endosomes (PubMed:18657069). Binds to and stabilizes the activated form of NOTCH1, increases its localization in endosomes and regulates its transcriptional activity (PubMed:21464124). {ECO:0000269|PubMed:11877457, ECO:0000269|PubMed:11877461, ECO:0000269|PubMed:12952931, ECO:0000269|PubMed:14617351, ECO:0000269|PubMed:17494869, ECO:0000269|PubMed:18657069, ECO:0000269|PubMed:21464124, ECO:0000269|PubMed:25653444}.; FUNCTION: (Microbial infection) By regulating clathrin-mediated endocytosis, AAK1 plays a role in the entry of hepatitis C virus as well as for the lifecycle of other viruses such as Ebola and Dengue. {ECO:0000269|PubMed:25653444, ECO:0000305|PubMed:31136173}.

Q9Y2X3

Main function of 5'-partner protein: FUNCTION: Required for 60S ribosomal subunit biogenesis (By similarity). Core component of box C/D small nucleolar ribonucleoprotein (snoRNP) particles. Required for the biogenesis of box C/D snoRNAs such as U3, U8 and U14 snoRNAs. {ECO:0000250, ECO:0000269|PubMed:15574333, ECO:0000269|PubMed:17636026, ECO:0000269|PubMed:19620283}.
Ensembl transtripts involved in fusion geneENST idsENST00000406297, ENST00000409085, 
ENST00000409068, ENST00000470281, 
ENST00000467734, ENST00000264279, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score19 X 13 X 11=27176 X 7 X 3=126
# samples 226
** MAII scorelog2(22/2717*10)=-3.62643913669732
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(6/126*10)=-1.0703893278914
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: AAK1 [Title/Abstract] AND NOP58 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: AAK1 [Title/Abstract] AND NOP58 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)AAK1(69732700)-NOP58(203160396), # samples:2
Anticipated loss of major functional domain due to fusion event.AAK1-NOP58 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
AAK1-NOP58 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
AAK1-NOP58 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
AAK1-NOP58 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr2:69732700/chr2:203160396)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across AAK1 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across NOP58 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000409085AAK1chr269732700-ENST00000264279NOP58chr2203160396+3559264627833281016
ENST00000406297AAK1chr269732700-ENST00000264279NOP58chr2203160396+3559264627833281016

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000409085ENST00000264279AAK1chr269732700-NOP58chr2203160396+0.0053068010.9946932
ENST00000406297ENST00000264279AAK1chr269732700-NOP58chr2203160396+0.0053068010.9946932

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for AAK1-NOP58

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
AAK1chr269732700NOP58chr22031603962646789GDAFATTSFSAGTGSLLNLAKHAAST

Top

Potential FusionNeoAntigen Information of AAK1-NOP58 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
AAK1-NOP58_69732700_203160396.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
AAK1-NOP58chr269732700chr22031603962646HLA-B15:16FSAGTGSLL0.89490.987817
AAK1-NOP58chr269732700chr22031603962646HLA-B07:10SFSAGTGSL0.15730.6584716
AAK1-NOP58chr269732700chr22031603962646HLA-C03:19FSAGTGSL0.99980.9968816
AAK1-NOP58chr269732700chr22031603962646HLA-C03:08FSAGTGSL0.99980.9782816
AAK1-NOP58chr269732700chr22031603962646HLA-C03:07FSAGTGSL0.99970.9953816
AAK1-NOP58chr269732700chr22031603962646HLA-C08:04FSAGTGSL0.99660.9912816
AAK1-NOP58chr269732700chr22031603962646HLA-C08:13FSAGTGSL0.99660.9912816
AAK1-NOP58chr269732700chr22031603962646HLA-C03:19FSAGTGSLL0.99920.9977817
AAK1-NOP58chr269732700chr22031603962646HLA-C03:08FSAGTGSLL0.9990.9836817
AAK1-NOP58chr269732700chr22031603962646HLA-C03:07FSAGTGSLL0.9990.9964817
AAK1-NOP58chr269732700chr22031603962646HLA-C15:06FSAGTGSLL0.99810.987817
AAK1-NOP58chr269732700chr22031603962646HLA-C15:04FSAGTGSLL0.99790.9852817
AAK1-NOP58chr269732700chr22031603962646HLA-C05:09FSAGTGSLL0.99710.9885817
AAK1-NOP58chr269732700chr22031603962646HLA-C04:06FSAGTGSLL0.99570.9869817
AAK1-NOP58chr269732700chr22031603962646HLA-C08:15FSAGTGSLL0.99380.9952817
AAK1-NOP58chr269732700chr22031603962646HLA-C01:17FSAGTGSLL0.99080.986817
AAK1-NOP58chr269732700chr22031603962646HLA-C08:04FSAGTGSLL0.99040.9932817
AAK1-NOP58chr269732700chr22031603962646HLA-C08:13FSAGTGSLL0.99040.9932817
AAK1-NOP58chr269732700chr22031603962646HLA-C06:03FSAGTGSLL0.98660.999817
AAK1-NOP58chr269732700chr22031603962646HLA-C12:04FSAGTGSLL0.9860.999817
AAK1-NOP58chr269732700chr22031603962646HLA-C12:12FSAGTGSLL0.98240.9842817
AAK1-NOP58chr269732700chr22031603962646HLA-C08:03FSAGTGSLL0.94160.9969817
AAK1-NOP58chr269732700chr22031603962646HLA-C03:14FSAGTGSLL0.92570.9957817
AAK1-NOP58chr269732700chr22031603962646HLA-C01:30FSAGTGSLL0.81820.99817
AAK1-NOP58chr269732700chr22031603962646HLA-C02:06FSAGTGSLL0.77020.9949817
AAK1-NOP58chr269732700chr22031603962646HLA-C03:08TSFSAGTGSL0.99880.9624616
AAK1-NOP58chr269732700chr22031603962646HLA-C03:03FSAGTGSL0.99980.9951816
AAK1-NOP58chr269732700chr22031603962646HLA-C03:04FSAGTGSL0.99980.9951816
AAK1-NOP58chr269732700chr22031603962646HLA-C03:05FSAGTGSL0.99960.9648816
AAK1-NOP58chr269732700chr22031603962646HLA-C03:17FSAGTGSL0.99960.9888816
AAK1-NOP58chr269732700chr22031603962646HLA-C03:06FSAGTGSL0.98830.996816
AAK1-NOP58chr269732700chr22031603962646HLA-B07:13FSAGTGSL0.70230.9177816
AAK1-NOP58chr269732700chr22031603962646HLA-C03:03FSAGTGSLL0.99930.9966817
AAK1-NOP58chr269732700chr22031603962646HLA-C03:04FSAGTGSLL0.99930.9966817
AAK1-NOP58chr269732700chr22031603962646HLA-C03:67FSAGTGSLL0.99840.9938817
AAK1-NOP58chr269732700chr22031603962646HLA-C03:05FSAGTGSLL0.9980.975817
AAK1-NOP58chr269732700chr22031603962646HLA-C15:05FSAGTGSLL0.99790.9766817
AAK1-NOP58chr269732700chr22031603962646HLA-C03:17FSAGTGSLL0.99790.9917817
AAK1-NOP58chr269732700chr22031603962646HLA-C15:02FSAGTGSLL0.99790.9804817
AAK1-NOP58chr269732700chr22031603962646HLA-C15:09FSAGTGSLL0.99790.9852817
AAK1-NOP58chr269732700chr22031603962646HLA-C03:02FSAGTGSLL0.99780.9917817
AAK1-NOP58chr269732700chr22031603962646HLA-C05:01FSAGTGSLL0.99710.9885817
AAK1-NOP58chr269732700chr22031603962646HLA-C04:03FSAGTGSLL0.9970.9755817
AAK1-NOP58chr269732700chr22031603962646HLA-C08:02FSAGTGSLL0.99380.9952817
AAK1-NOP58chr269732700chr22031603962646HLA-C12:02FSAGTGSLL0.9920.9953817
AAK1-NOP58chr269732700chr22031603962646HLA-C01:02FSAGTGSLL0.99160.9859817
AAK1-NOP58chr269732700chr22031603962646HLA-C01:03FSAGTGSLL0.99120.9797817
AAK1-NOP58chr269732700chr22031603962646HLA-C16:04FSAGTGSLL0.99080.9961817
AAK1-NOP58chr269732700chr22031603962646HLA-C12:03FSAGTGSLL0.98920.9961817
AAK1-NOP58chr269732700chr22031603962646HLA-C03:06FSAGTGSLL0.98170.9967817
AAK1-NOP58chr269732700chr22031603962646HLA-C08:01FSAGTGSLL0.94160.9969817
AAK1-NOP58chr269732700chr22031603962646HLA-C16:02FSAGTGSLL0.89610.997817
AAK1-NOP58chr269732700chr22031603962646HLA-C16:01FSAGTGSLL0.87080.9934817
AAK1-NOP58chr269732700chr22031603962646HLA-B35:13FSAGTGSLL0.75340.9857817
AAK1-NOP58chr269732700chr22031603962646HLA-C02:02FSAGTGSLL0.75040.9957817
AAK1-NOP58chr269732700chr22031603962646HLA-C02:10FSAGTGSLL0.75040.9957817
AAK1-NOP58chr269732700chr22031603962646HLA-B15:30FSAGTGSLL0.70670.9893817
AAK1-NOP58chr269732700chr22031603962646HLA-C17:01FSAGTGSLL0.33830.9915817
AAK1-NOP58chr269732700chr22031603962646HLA-B07:13FSAGTGSLL0.29780.9129817
AAK1-NOP58chr269732700chr22031603962646HLA-C14:03SFSAGTGSL0.27640.9899716
AAK1-NOP58chr269732700chr22031603962646HLA-C14:02SFSAGTGSL0.27640.9899716

Top

Potential FusionNeoAntigen Information of AAK1-NOP58 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
AAK1-NOP58_69732700_203160396.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
AAK1-NOP58chr269732700chr22031603962646DRB1-0802GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-0804GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-0804AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-0809GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-0820GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-0820AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-0821GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-0824GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-0828GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-0828AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-0831GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-0831AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-1101GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1103GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1104GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1104AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-1105GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1106GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1106AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-1109GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1110GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1112GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1115GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1118GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1118AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-1124GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1125GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1125AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-1127GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1128GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1129GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1132GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1133GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1135GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1135AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-1137GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1138GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1138AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-1139GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1141GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1142GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1143GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1143AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-1144GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1144AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-1146GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1146AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-1147GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1147AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-1148GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1149GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1150GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1150AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-1151GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1154GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1156GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1156AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-1157GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1158GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1158AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-1159GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1160GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1160AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-1161GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1162GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1163GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1166GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1167GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1167AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-1172GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1174GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1175GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1176GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1177GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1177AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-1178GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1178AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-1181GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1183GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1184GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1184AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-1185GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1188GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1188AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-1190GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1191GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1192GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1192AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-1194GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1195GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1196GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1204GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1204AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-1209GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1209AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-1305GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1306GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1306AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-1307GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1308GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1311GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1311AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-1314GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1317GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1318GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1318AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-1324GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1326GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1342GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1342AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-1350GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1362GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1370GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1372GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1384GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1406GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1412GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1415GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1415AGTGSLLNLAKHAAS1025
AAK1-NOP58chr269732700chr22031603962646DRB1-1420GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1427GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1429GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1452GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1483GTGSLLNLAKHAAST1126
AAK1-NOP58chr269732700chr22031603962646DRB1-1484GTGSLLNLAKHAAST1126

Top

Fusion breakpoint peptide structures of AAK1-NOP58

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
9642TSFSAGTGSLLNLAAAK1NOP58chr269732700chr22031603962646

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of AAK1-NOP58

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN9642TSFSAGTGSLLNLA-6.58153-6.69493
HLA-B14:023BVN9642TSFSAGTGSLLNLA-6.20518-7.24048
HLA-B52:013W399642TSFSAGTGSLLNLA-6.29254-6.40594
HLA-B52:013W399642TSFSAGTGSLLNLA-4.56924-5.60454
HLA-A24:025HGA9642TSFSAGTGSLLNLA-8.22653-9.26183
HLA-A24:025HGA9642TSFSAGTGSLLNLA-7.34321-7.45661
HLA-B44:053DX89642TSFSAGTGSLLNLA-6.07307-6.18647
HLA-B44:053DX89642TSFSAGTGSLLNLA-5.07219-6.10749
HLA-A02:016TDR9642TSFSAGTGSLLNLA-5.90165-6.01505
HLA-A02:016TDR9642TSFSAGTGSLLNLA-1.391-2.4263

Top

Vaccine Design for the FusionNeoAntigens of AAK1-NOP58

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
AAK1-NOP58chr269732700chr2203160396616TSFSAGTGSLCCTCATTTTCTGCTGGAACTGGTTCTCTTT
AAK1-NOP58chr269732700chr2203160396716SFSAGTGSLCATTTTCTGCTGGAACTGGTTCTCTTT
AAK1-NOP58chr269732700chr2203160396816FSAGTGSLTTTCTGCTGGAACTGGTTCTCTTT
AAK1-NOP58chr269732700chr2203160396817FSAGTGSLLTTTCTGCTGGAACTGGTTCTCTTTTAA

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
AAK1-NOP58chr269732700chr22031603961025AGTGSLLNLAKHAASCTGGAACTGGTTCTCTTTTAAATTTGGCCAAGCATGCAGCTTCTA
AAK1-NOP58chr269732700chr22031603961126GTGSLLNLAKHAASTGAACTGGTTCTCTTTTAAATTTGGCCAAGCATGCAGCTTCTACCG

Top

Information of the samples that have these potential fusion neoantigens of AAK1-NOP58

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
ESCAAAK1-NOP58chr269732700ENST00000406297chr2203160396ENST00000264279TCGA-LN-A4A8

Top

Potential target of CAR-T therapy development for AAK1-NOP58

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to AAK1-NOP58

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to AAK1-NOP58

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource